-
PurposeRetroviral expression of p62
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 71305 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepBABE-puro
-
Backbone manufacturerAddgene plasmid # 1764
- Backbone size w/o insert (bp) 5169
-
Vector typeMammalian Expression, Retroviral
-
Selectable markersPuromycin
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)NEB Stable
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameSequestosome-1
-
Alt namep62
-
Alt nameSQSTM1
-
SpeciesH. sapiens (human)
-
Entrez GeneSQSTM1 (a.k.a. A170, DMRV, EBIAP, FTDALS3, NADGP, OSIL, PDB3, ZIP3, p60, p62, p62B)
-
Tag
/ Fusion Protein
- HA (N terminal on insert)
Cloning Information
- Cloning method Unknown
- 5′ sequencing primer pBABE 5'
- 3′ sequencing primer pBABE 3' (Common Sequencing Primers)
Resource Information
-
A portion of this plasmid was derived from a plasmid made byHuman p62 cDNA was a kind gift from Dr. T. Johansen.
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
This plasmid contains a T375A mutation within the Sequestosome-1 translation compared to NP_003891.1. The depositor states that this mutation does not affect plasmid function.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pBABEpuro-HA-p62 was a gift from Jayanta Debnath (Addgene plasmid # 71305 ; http://n2t.net/addgene:71305 ; RRID:Addgene_71305) -
For your References section:
Autophagy restricts proliferation driven by oncogenic phosphatidylinositol 3-kinase in three-dimensional culture. Chen N, Eritja N, Lock R, Debnath J. Oncogene. 2013 May 16;32(20):2543-54. doi: 10.1038/onc.2012.277. Epub 2012 Jul 9. 10.1038/onc.2012.277 PubMed 22777351